These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28954785)

  • 41. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.
    Brown NA; Plouffe KR; Yilmaz O; Weindorf SC; Betz BL; Carey TE; Seethala RR; McHugh JB; Tomlins SA; Udager AM
    Mod Pathol; 2021 Jun; 34(6):1133-1142. PubMed ID: 33203919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Squamous cell carcinoma arising in a mature cystic teratoma.
    Gupta V; Sood N
    Indian J Pathol Microbiol; 2009; 52(2):271-3. PubMed ID: 19332939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can malignant transformation in mature cystic teratoma be preoperatively predicted?
    Futagami M; Yokoyama Y; Mizukami H; Shigeto T; Mizunuma H
    Eur J Gynaecol Oncol; 2012; 33(6):662-5. PubMed ID: 23327068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.
    Schwaederle M; Elkin SK; Tomson BN; Carter JL; Kurzrock R
    Cell Cycle; 2015; 14(14):2355-61. PubMed ID: 26030731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A series of malignant ovarian cancers arising from within a mature cystic teratoma: a single institution experience.
    Black JD; Roque DM; Pasternak MC; Buza N; Rutherford TJ; Schwartz PE; McCarthy S; Ratner E
    Int J Gynecol Cancer; 2015 Jun; 25(5):792-7. PubMed ID: 25790042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p53 mutation in carcinomas arising in ovarian cystic teratomas.
    Fujii T; Oguni S; Kikuchi M; Kanai N; Saito K
    Pathol Int; 1995 Sep; 45(9):649-54. PubMed ID: 8548037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Kobayashi H; Sekiguchi I; Konnai K; Terao T; Sato I
    Oncology; 1995; 52(4):287-90. PubMed ID: 7777241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
    Bochtler T; Reiling A; Endris V; Hielscher T; Volckmar AL; Neumann O; Kirchner M; Budczies J; Heukamp LC; Leichsenring J; Allgäuer M; Kazdal D; Löffler H; Weichert W; Schirmacher P; Stenzinger A; Krämer A
    Int J Cancer; 2020 Jun; 146(11):3053-3064. PubMed ID: 31970771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignant transformation arising from mature cystic teratoma of the ovary: a retrospective study of 20 cases.
    Sakuma M; Otsuki T; Yoshinaga K; Utsunomiya H; Nagase S; Takano T; Niikura H; Ito K; Otomo K; Tase T; Watanabe Y; Yaegashi N
    Int J Gynecol Cancer; 2010 Jul; 20(5):766-71. PubMed ID: 20973266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Squamous carcinoma coexistent with teratoma of ovary: a clinicopathological study of 12 cases diagnosed over a 10-year period at a tertiary cancer referral center.
    Rekhi B; Parikh P; Deodhar KK; Menon S; Maheshwari A; Kerkar R; Gupta S
    J Cancer Res Ther; 2015; 11(1):211-5. PubMed ID: 25879364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unique miRNA profiling of squamous cell carcinoma arising from ovarian mature teratoma: comprehensive miRNA sequence analysis of its molecular background.
    Yoshida K; Yokoi A; Kagawa T; Oda S; Hattori S; Tamauchi S; Ikeda Y; Yoshikawa N; Nishino K; Utsumi F; Niimi K; Suzuki S; Shibata K; Kajiyama H; Yokoi T; Kikkawa F
    Carcinogenesis; 2019 Dec; 40(12):1435-1444. PubMed ID: 31353396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful treatment of advanced squamous cell carcinoma arising from mature cystic teratoma of the ovary with homologous recombination deficiency: A case report.
    Tamura R; Yamaguchi M; Kitani Y; Nishikawa N; Kawasaki T; Kikuchi A
    Int J Surg Case Rep; 2023 Jun; 107():108329. PubMed ID: 37216734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
    An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.
    Ludwig ML; Kulkarni A; Birkeland AC; Michmerhuizen NL; Foltin SK; Mann JE; Hoesli RC; Devenport SN; Jewell BM; Shuman AG; Spector ME; Carey TE; Jiang H; Brenner JC
    Oral Oncol; 2018 Dec; 87():144-151. PubMed ID: 30527230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Araujo IB; Pinheiro MV; Zanvettor PH; Studart EJ; Filho DF; Coupland SE
    Int J Gynecol Pathol; 2016 Mar; 35(2):176-84. PubMed ID: 26367783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomic profiles of Japanese patients with vulvar squamous cell carcinoma.
    Fujii E; Kato MK; Yamaguchi M; Higuchi D; Koyama T; Komatsu M; Hamamoto R; Ishikawa M; Kato T; Kohno T; Shiraishi K; Yoshida H
    Sci Rep; 2024 Jun; 14(1):13058. PubMed ID: 38844774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic Profiling of Malignant Melanoma Arising from an Ovarian Mature Cystic Teratoma: A Case Report.
    Nakamura K; Aimono E; Takamatsu R; Tanishima S; Tohyama T; Sasano K; Sakuma H; Nishihara H
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670958
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clear Cell Squamous Cell Carcinoma of the Maxillary Gingiva Associated with PIK3CA and HRAS Mutations: Report of a Case and Literature Review.
    Hirose K; Shibahara T; Teramoto A; Usami Y; Ono S; Iwamoto Y; Murakami S; Oya K; Uzawa N; Motooka D; Hori Y; Morii E; Toyosawa S
    Head Neck Pathol; 2023 Dec; 17(4):1026-1033. PubMed ID: 37735286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
    Regauer S; Kashofer K; Reich O
    Mod Pathol; 2019 Mar; 32(3):415-422. PubMed ID: 30291345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.